Intravenous Dexamethasone Effectiveness in Post Caesarean Section Analgesia

• Status: Completed
• Trial end date: 2021-01-04
• Target enrollment: 0
• Participant gender: Female

Summary

The management of postpartum pain is essential to ensure early rehabilitation for parturients. Intravenous dexamethasone has a potent analgesic action when used in the context of general anesthesia. Nevertheless, it remains poorly studied in combination with spinal anesthesia (SA). The aim of this study was to assess the analgesic effect of intravenous dexamethasone after caesarean section under SA.

Methods: We conducted a prospective, randomized, double-blinded study including 84 ASA II-III parturient at term who were proposed for caesarean section under SA. Parturient were randomized into two groups: Dexamethasone group (DG) who received 8mg of intravenous dexamethasone (2ml) immediately after SA and placebo group (PG) who received 2ml of isotonic saline. The analgesic protocol was standardized and we opted for Tramadol as rescue analgesic. The main outcome is the use of Tramadol in the first 24 hours postpartum..

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mongi Slim Hospital
• Treatments: Dexamethasone

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists (ASA) statue II-III,

• a pregnancy term >= 37 weeks

• elective cesarean section

• Pfannenstiel incision

Exclusion Criteria:

• severe hypertension / preeclampsia

• poorly balanced diabetes mellitus

• allergy to one of the study drugs

• patients with chronic pain or long-term use of opioids

• patients on long-term corticosteroid therapy.